Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Effects of sepsis and dichloroacetate on hepatic transcriptome

ABSTRACT: Effects of sepsis and dichloroacetate on hepatic transcriptome

PROVIDER: PRJNA703033 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR13748300_1.fastq.gz	Fastqsanger.gz
	SRR13748300_2.fastq.gz	Fastqsanger.gz
	SRR13748301_1.fastq.gz	Fastqsanger.gz
	SRR13748301_2.fastq.gz	Fastqsanger.gz
	SRR13748290_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 24

Similar Datasets

Effects of sepsis and dichloroacetate on hepatic transcriptome

Project description:This study was designed to capture the effects of chronic sepsis (30 hours) on hepatic gene expression. Furthermore, we characterized the effects of pharmacological targeting of the pyrruvate dehydrogenase kinase pathway via dichloroacetate treatment in septic mice.

2021-02-22 | GSE167127 | GEO

Hepatic PPARα dysfunction in porcine sepsis

Project description:Hepatic PPARα dysfunction in porcine sepsis

| PRJNA904738 | ENA

Hepatic PPARalpha is critical in the metabolic adaptation to sepsis

Project description:Sepsis induces a metabolic shift from glucose to fatty acid utilization that is key to survival for the organism. Here we used microarray analysis to characterize hepatic gene expression in conditions mimicking sepsis.

2019-02-01 | GSE121847 | GEO

Hepatic PPARα function and lipid metabolic pathways are dysregulated in polymicrobial sepsis

Project description:Despite intensive research and constant medical progress, sepsis remains one of the most urgent unmet medical needs of today. Most studies have been focused on the inflammatory component of the disease, however, recent advances support the notion that sepsis is accompanied by extensive metabolic perturbations. During times of limited caloric intake and high energy needs, the liver acts as the central metabolic hub in which PPARa is crucial to coordinate the breakdown of fatty acids. The role of hepatic PPARa in liver dysfunction during sepsis has hardly been explored. We demonstrate that sepsis leads to a starvation response that is hindered by the rapid decline of hepatic PPARa levels, causing excess free fatty acids, leading to lipotoxicity, and glycerol. In addition, treatment of mice with the PPARa agonist pemafibrate protects against bacterial sepsis by improving hepatic PPARa function, reducing lipotoxicity and tissue damage. Since lipolysis is also increased in sepsis patients and pemafibrate protects after the onset of sepsis, these findings may point towards new therapeutic leads in sepsis.

2019-11-23 | GSE139484 | GEO

HNF4α contributes to hepatic CAR dysfunction in polymicrobial sepsis

Project description:Constitutive androstane receptor (CAR) is a xenobiotic nuclear receptor mainly expressed in the liver, where it regulates drug metabolism and energy homeostasis. CAR has emerged as a promising therapeutic target for diabetes, fatty liver disease, and alcoholic liver disease, but it has not been investigated in the context of sepsis. Here, we show that sepsis impairs CAR function in the liver, partly due to reduced transcription mediated by HNF4α, the key liver identity transcription factor, and partly due to decreased DNA binding, caused by chromatin remodeling, also mediated by HNF4α. This impairment leads to the downregulation of several genes and proteins involved in monocarboxylic acid, fatty acid, and xenobiotic metabolism, contributing to increased sepsis lethality, and is associated with an elevated hepatic acute phase response. LC-MSMS analysis was used to identify the proteins differentially expressed in the liver 24h after sepsis onset.

2025-09-15 | PXD062961 | Pride

HNF4α contributes to hepatic CAR dysfunction in polymicrobial sepsis

Project description:Constitutive androstane receptor (CAR) is a xenobiotic nuclear receptor mainly expressed in the liver, where it regulates drug metabolism and energy homeostasis. CAR has emerged as a promising therapeutic target for diabetes, fatty liver disease, and alcoholic liver disease, but it has not been investigated in the context of sepsis. Here, we show that sepsis impairs CAR function in the liver, partly due to reduced transcription mediated by HNF4α, the key liver identity transcription factor, and partly due to decreased DNA binding, caused by chromatin remodelling, also mediated by HNF4α. This impairment leads to the downregulation of several genes involved in monocarboxylic acid, fatty acid, and xenobiotic metabolism, contributing to increased sepsis lethality, and is associated with an elevated hepatic acute phase response. NCT protects against sepsis by enhancing HNF4α binding to the CAR promoter, thereby increasing both CAR transcription and activity.

2025-08-31 | GSE294204 | GEO

A critical role for Hepatocyte Nuclear Factor 4 alpha in polymicrobial sepsis-associated metabolic reprogramming and death: ATAC-seq after CLP sepsis model

Project description:In sepsis, limited food intake and increased energy expenditure induce a starvation response, which is compromised by a quick decline in expression of hepatic PPARα, a transcription factor essential in intracellular catabolism of free fatty acids. The mechanism upstream of this PPARα downregulation is unknown. We found that sepsis causes a progressive hepatic loss-of-function of HNF4α, which has strong impact on the expression of several important nuclear receptors, including PPARα. HNF4α depletion in hepatocytes dramatically increases sepsis lethality, steatosis and organ damage and prevents an adequate response towards IL6, which is critical for liver regeneration and survival. An HNF4α agonist protects against sepsis at all possible levels, irrespectively of bacterial loads, suggesting HNF4α is crucial in disease tolerance to sepsis. In conclusion, hepatic HNF4α fails in sepsis, causing PPARα downregulation and metabolic problems and a disturbed IL6-mediated acute phase response. The data open new insights and therapeutic options in sepsis.

2023-10-31 | GSE244821 | GEO

A critical role for Hepatocyte Nuclear Factor 4 alpha in polymicrobial sepsis-associated metabolic reprogramming and death: HNF4A ChIP-seq in the CLP sepsis model (ChIP-Seq)

2023-10-31 | GSE245682 | GEO

Hepatic PPARα dysfunction in porcine sepsis

Project description:Despite decades of research, sepsis remains one of the most urgent unmet medical needs. Clinical trials in sepsis have mainly focused on targeting the inflammatory pathway, however, recent data indicate that sepsis should also be seen as a metabolic disease. Targeting metabolic dysregulations that take place in sepsis might uncover novel therapeutic opportunities to treat human sepsis patients. The role of PPARα in liver dysfunction during sepsis has recently been described, and restoring PPARα signaling proves to be successful in murine sepsis. To find out whether this therapy might also be helpful in human sepsis patients, we analyzed metabolic perturbations in liver of a porcine fecal peritonitis model. Resuscitation with fluids, antimicrobial therapy and abdominal drainage were applied to the pigs in order to mimic human clinical care. By using RNA-seq, we detected problems with PPARα signaling in the livers of septic pigs and reduced PPARα levels correlated well with disease severity. As PPARα regulates the expression of many genes involved in FA oxidation, reduced expression of these target genes concomitant with increased FFAs in plasma and ectopic lipid deposition in the liver was observed. The results obtained in pigs are in agreement with earlier observations in mice and support the potential of targeting defective PPARα signaling in the clinic.

2022-11-28 | GSE218636 | GEO

HNF4α contributes to hepatic CAR dysfunction in polymicrobial sepsis

Project description:HNF4α contributes to hepatic CAR dysfunction in polymicrobial sepsis

| PRJNA1248547 | ENA